Concerns about health care during the coronavirus
Agrícolas, bomberos y azafatas buscan estar entre los primeros en recibir la vacuna
Se espera que los trabajadores de salud
Pfizer’s Xalkori (crizotinib) Approved by FDA for ALK-positive Anaplastic Large Cell Lymphoma in Children and Young Adults
NEW YORK–(BUSINESS WIRE) January 14, 2021 —
FDA Approves Supplemental New Drug Application for Takeda’s Iclusig (ponatinib) for Adult Patients with Resistant or Intolerant Chronic-Phase CML
December 18, 2020 — Takeda Pharmaceutical Company
Pfizer Update On Our U.S. COVID-19 Vaccine Candidate Distribution Preparedness
NEW YORK, 16 November 2020 — Pfizer (NYSE: PFE) today announced
RDIF and União Química File Documents for Registration of Sputnik V Vaccine with Regulator in Brazil
Moscow, October 30, 2020 –The Russian Direct Investment
Tezepelumab NAVIGATOR Phase III Trial Met Primary Endpoint of a Statistically Significant and Clinically Meaningful Reduction in Exacerbations in a Broad Population of Patients with Severe Asthma
10 November 2020 — AstraZeneca and Amgen
GeneTx and Ultragenyx Announce Positive Interim Phase 1/2 Data on Investigational GTX-102 Demonstrating Improvement in Patients with Angelman Syndrome
SARASOTA, Fla. and NOVATO, Calif., Oct. 26,
An Open Letter from Merdad Parsey, Chief Medical Officer, Gilead Sciences
October 22, 2020 — In less than
CTI BioPharma to Submit a New Drug Application (NDA) for the Accelerated Approval of Pacritinib for the Treatment of Myelofibrosis Patients with Severe Thrombocytopenia
SEATTLE, Sept. 29, 2020 /PRNewswire/ — CTI BioPharma Corp. (Nasdaq: CTIC)